Jan 10, 2023 / 12:30AM GMT
Casey Rene Woodring - JPMorgan Chase & Co, Research Division - Research Analyst
All right. Hello, everybody. Thanks for joining us today. My name is Casey Woodring from the Life Science Tools and Diagnostics team here at JPMorgan. I'm pleased to be joined here today by Sotera Health CEO, Michael Petras, is here to my left. There will be a Q&A portion following the company presentation. So with that, Michael.
Michael B. Petras - Sotera Health Company - Chairman & CEO
Great. Thanks, Casey, and good afternoon, everybody. Thanks for joining us. We'll get through forward-looking statements. Some of the statements I'll make today may be considered forward-looking statements. Please refer to our SEC filings for a description of the risks and uncertainties that could cause our actual results to differ materially from projected or implied.
The company assumes no obligation to update forward-looking statements. During the discussion today, we may talk about certain non-GAAP financial measures, including adjusted EBITDA. And you can refer to our SEC
Sotera Health Co at JPMorgan Healthcare Conference Transcript
Jan 10, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers